Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.
Liu J, Li J, Li P, Wang Y, Liang Z, Jiang Y, Li J, Feng C, Wang R, Chen H, Zhou C, Zhang J, Yang J, Liu P.
Liu J, et al. Among authors: zhou c.
Sci Rep. 2017 Feb 7;7:42125. doi: 10.1038/srep42125.
Sci Rep. 2017.
PMID: 28169360
Free PMC article.